The tumor suppressor role of Parkin has been implicated with the expression correlation studies where low Parkin expression was associated with poor GBM prognosis (Freije et al., 2004; Wang et al., 2017; de Castro et al., 2021). This evidence concerns the gene PRKN and glioblastoma.